Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity

Anthony, 2008, Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc, Science, 320, 373, 10.1126/science.1154315 Anthony, 2010, A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs, Journal of Clinical Immunology, 30, 9, 10.1007/s10875-010-9405-6 Asher, 2005, The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection, Proceedings of the National Academy of Sciences of the United States of America, 102, 12897, 10.1073/pnas.0506211102 Bergelson, 1997, Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5, Science, 275, 1320, 10.1126/science.275.5304.1320 Bruning, 2003, CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta, Gene Therapy, 10, 198, 10.1038/sj.gt.3301887 Carter, 2011, Introduction to current and future protein therapeutics: a protein engineering perspective, Experimental Cell Research, 317, 1261, 10.1016/j.yexcr.2011.02.013 Chow, 1991, Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage, Laboratory Investigation, 64, 55 Dörner, 2006, Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury, Journal of Molecular Medicine, 84, 842, 10.1007/s00109-006-0076-y Dörner, 2004, Alternatively spliced soluble coxsackie-adenovirus receptors inhibit coxsackievirus infection, Journal of Biological Chemistry, 279, 18497, 10.1074/jbc.M311754200 Daly, 2005, Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production, Journal of Molecular Recognition, 18, 119, 10.1002/jmr.687 Excoffon, 2007, Functional effects of coxsackievirus and adenovirus receptor glycosylation on homophilic adhesion and adenoviral infection, Journal of Virology, 81, 5573, 10.1128/JVI.02562-06 Goodfellow, 2005, Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors, Journal of Virology, 79, 12016, 10.1128/JVI.79.18.12016-12024.2005 Hauwel, 2005, Molecular and cellular insights into the coxsackie–adenovirus receptor: role in cellular interactions in the stem cell niche, Brain Research Reviews, 48, 265, 10.1016/j.brainresrev.2004.12.017 He, 2001, Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor, Natural Structural Biology, 8, 874, 10.1038/nsb1001-874 Henke, 2003, Vaccination procedures against Coxsackievirus-induced heart disease, Expert Review of Vaccines, 2, 805, 10.1586/14760584.2.6.805 Hua, 2009, The dual role of the cystathionine γ-lyase/hydrogen sulfide pathway in CVB3-induced myocarditis in mice, Biochemical and Biophysical Research Communications, 388, 595, 10.1016/j.bbrc.2009.08.064 Jiang, 2007, Solution structure of the coxsackievirus and adenovirus receptor domain 2, Protein Science, 16, 539, 10.1110/ps.062643507 Li, 2007, Expression of recombinant proteins in Pichia pastoris, Applied Biochemistry and Biotechnology, 142, 105, 10.1007/s12010-007-0003-x Li, 2008, Optimization of the expression of hepatitis B virus e gene in Pichia pastoris and immunological characterization of the product, Journal of Biotechnology, 138, 1, 10.1016/j.jbiotec.2008.07.1989 Lim, 2006, Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis, Cardiovascular Research, 71, 517, 10.1016/j.cardiores.2006.05.016 Pinkert, 2009, Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor, Circulation, 120, 2358, 10.1161/CIRCULATIONAHA.108.845339 Reed, 1938, A simple method of estimating fifty per cent endpoints, American Journal of Epidemiology, 27, 493, 10.1093/oxfordjournals.aje.a118408 Shi, 2009, Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo, Journal of the American College of Cardiology, 53, 1219, 10.1016/j.jacc.2008.10.064 Takada, 1995, Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model: antiviral and anti-inflammatory effects, Circulation, 92, 1604, 10.1161/01.CIR.92.6.1604 Wang, 2008, Protein expression and purification of human Zbtb7A in Pichia pastoris via gene codon optimization and synthesis, Protein Expression and Purification, 60, 97, 10.1016/j.pep.2008.03.017 Yanagawa, 2004, Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice, Journal of Infectious Diseases, 189, 1431, 10.1086/382598